NOT:ETR
Novartis AG
145,66 €
arrow_downward
-0,74%(-1,08) 1D
6 nën, 5:35:44 m.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NOT...
Hap
143,24 €
I lartë
145,66 €
I ulët
142,26 €
Kapitalizimi i tregut
335,52Â mld
Vëllimi mesatar
5,49 mijë
Vëllimi
3,31 mijë
Maksimumi 52-javor
147,88 €
Minimumi 52-javor
107,00 €
Numri i punonjësve
75 mijë
Hap
143,24 €
I lartë
145,66 €
I ulët
142,26 €
Kapitalizimi i tregut
335,52Â mld
Vëllimi mesatar
5,49 mijë
Vëllimi
3,31 mijë
Maksimumi 52-javor
147,88 €
Minimumi 52-javor
107,00 €
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Seeking Alpha
·
1 orë më parë
Novartis is said to be abandoning Ionis heart drug after late-stage trial setback
Investing.com
·
2 orë më parë
Novartis shelves potential blockbuster pelacarsen as landmark study fails
Reuters
·
3 orë më parë
Trial failures of Novartis, Novo Nordisk heart drugs leave experts guessing
Profili
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Rreth Novartis AG
Drejtori ekzekutivVasant Narasimhan
Punonjësit75,3 mijë
Themeluar më7 mar 1996
SeliaBasel, Basel City, Zvicër
SektoriHealth Care
Industria-
Uebsajtinovartis.com